Aquaculture Vaccines Market - By Type of Vaccines (Inactivated, Live), By Route of Administration (Immersion Vaccines, Injection Vaccines, Oral Vaccines), By Application (Bacterial Infection, Viral Infection), By Species (Salmon, Trout, Tilapia) & Global Forecast, 2023 – 2032

Industry Statistics

Aquaculture Vaccines Market size surpassed USD 214.6 million in 2022 and is estimated to witness 7.6% CAGR between 2023 and 2032. Aquatic food consumption is on the rise because of increased supply, evolving consumer preferences & tastes, technological advancements, and wage inflation. Hence, the rising aquaculture industry is likely to boost the demand for aquaculture vaccines for higher production, fuelling the global market demand throughout the forecast period.
 

Get more details on this report - Request Free Sample PDF
 

Additional factors likely to have a major impact on the development of the aquaculture vaccines market include the rising frequency of infectious diseases among marine animals and new product advancements made by industry participants to treat these diseases. Thus, the introduction of new aquaculture vaccines to the market is further anticipated to spur market expansion.

The production and commercialization of aquaculture vaccines may be hampered by stringent regulatory frameworks governing vaccine approvals. Some governments and public entities have issued recommendations to guarantee the safe and successful use of fish farming vaccinations. Moreover, firms are quickly implementing In Process Quality Control (IPQC) and Good Manufacturing Practices (GMP) (GMPs). Vaccine clearance procedures governed by the US Food and Drug Administration and the European Union are time-consuming and inhibit new market entrants. Before any vaccine is certified for aquacultural use, it must undergo extensive impact surveillance and pharmacovigilance.
 

Increasing demand for aquaculture vaccines for higher production to proliferate the market growth

The increasing demand of aquaculture vaccines for higher animal-derived food production is anticipated to proliferate the market growth. The aquaculture industry has grown quickly in recent decades. A sustainable aquaculture business is crucial for the global food supply and economy since it contributes significantly to the provision of high-quality protein meals for people. It also helps in plant producing vaccines like genetically modified crops with desired traits have been created via plant genetic engineering, which has also been used to create vaccines.
 

Advances in technology forinactivated aquaculture vaccines will support market statistics

Get more details on this report - Request Free Sample PDF
 

Based on type of vaccines, the aquaculture vaccines market is segmented as Inactivated vaccine, Live vaccine, and others. The inactive vaccines segment is expected to reach around USD 362.1 million by 2032. Antibiotics and probiotics appear to be less effective when novel mutant strains emerge, and disease-causing microorganisms gain resistance to routinely used antibiotics. Therefore, as a result, vaccinations produced using reducing molecular methods can be viewed as an effective method of treating disease-causing in aquatic creatures and assist to boost immunity to a particular disease or group of infections.
 

Aquaculture farming's surging demand for anti-infectives will fuel injectable vaccine delivery expansion

Based on Route of Administration, aquaculture vaccines market is segmented as Immersion vaccines, Injection vaccines, Oral vaccines, and others. The Injection vaccines segment accounted for around USD 139.1 million in 2022. Injection vaccines are an efficient method of eliciting an antibody response in fish. The injection might be intramuscular or intraperitoneal. Most aquaculture vaccinations defend against bacterial infections. They can be taken through injections or oral intake (intraperitoneal or intramuscular).
 

Cost effectiveness of bacterial infection aquaculture vaccines propel the market growth

Based on application, the aquaculture vaccines market is segmented as Bacterial infection, Viral infection, and others. The bacterial infection segment is estimated to show a lucrative CAGR of over 7.5% from 2023 to 2032. A bacterial infection develops when germs enter the body, multiply, and induce a response. In aquatic creatures, disease-causing microorganisms can be effectively treated using vaccines created techniques are effective, advanced molecular technology, which are cost effective.
 

Market expansion in Europe will be spurred by large-scale fish farming operations

Get more details on this report - Request Free Sample PDF
 

Norway aquaculture vaccines market is anticipated to reach more than USD 96.16 million by 2032. The significant market share is owing to several factors including presence of major market players, an increase in the demand for Aquaculture Vaccines, and increasing supply chain for the vaccines. Several market players in the region are engaged in new product development & commercialization that facilitates the Aquaculture Vaccines industrial expansion in the region.
 

In January 2023, ScaleAQ collaborated with fish vaccination specialist Skala Maskon by this the firm intends to broaden its value chain to become a whole supplier and partner to the farming sector. This is a strategic and significant purchase that brings together a diversified and robust expertise environment within the aquaculture sector's supply business. It will boost the company's position as a holistic supplier of vital infrastructure for the agricultural industry. Thus, the above-mentioned factors are projected to boost the European Aquaculture Vaccines industry growth during the analysis timeframe.
 

Strategies adopted by major market players will surge the industry growth

Some of the major market players operating in the Aquaculture Vaccines industry are Zoetis Inc., Merck & Co., Inc., HIPRA, Tecnovax, Virbac, Veterquimica S.A, Nisseiken Co. Ltd., Phibro Animal Health Corporation, Vaxxinova International BV, Kyoto Biken Laboratories, Inc., among others. These organizations are concentrating their efforts on strategic partnerships, mergers, and acquisitions to maintain their competitive advantage. For instance, In July 2020, Zoetis acquired Benchmark Holdings, Plc Fish Vet Company to expand the company's global presence and analytical skills.
 

Impact of COVID-19 on Aquaculture Vaccines market trends

The outbreak of the COVID-19 pandemic in 2020 hindered aquaculture vaccine manufacturing throughout the globe. The overall business performance was affected by a substantial increase in the spread of illness and pandemic-related disease and death, as well as major supply chain disruptions. Owing to lockdown constraints and social distancing conventions, aquaculture vaccine production has been hampered by a labour shortage and an increased focus on making COVID-19 vaccines.
 

Aquaculture Vaccines market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:

By Type of vaccines

• Inactivated vaccines
• Live vaccines
• Others

By Route of Administration

• Immersion vaccines
• Injection vaccines
• Oral vaccines

By Application

• Bacterial infection
• Viral infection
• Others

By Species

• Salmon
• Trout
• Tilapia
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Norway
  • Ireland
  • Turkey
  • Denmark
• Asia Pacific
  • China
  • Indonesia
  • Philippines
  • Thailand
  • Australia
  • New Zealand 
• Latin America
  • Brazil
  • Mexico
  • Chile
• Middle East & Africa
  • Iran
  • Egypt